RUNX1-driven endothelial-to-mesenchymal transition contributes to remodelling in LMNA cardiomyopathy
- 11 August 2026
- journal article
- Published by Oxford University Press (OUP) in European Heart Journal
Abstract
Background and Aims: LMNA-related dilated cardiomyopathy (LMNA-DCM) is a progressive genetic disorder characterized by conduction disease, malignant arrhythmias, myocardial fibrosis, and heart failure. Although LMNA mutations have traditionally been associated with cardiomyocyte-intrinsic defects, the mechanisms driving fibrotic remodelling remain incompletely understood. Methods: Spatial transcriptomics and integrated single-nuclei multiomics were performed on explanted human LMNA-DCM hearts to define endothelial transcriptional and epigenomic states associated with fibrosis. Patient-specific induced pluripotent stem cell-derived endothelial cells, engineered cardiac organoids, and the LMNAH222P/H222P mouse model were used to investigate RUNX1-mediated endothelial-to-mesenchymal transition (EndoMT). Genetic and pharmacological RUNX1 inhibition strategies were evaluated in vitro and in vivo. Results: Endothelial populations exhibiting EndoMT-associated transcriptional and epigenomic signatures were identified in human LMNA-DCM hearts. LMNA induced pluripotent stem cell-derived endothelial cells demonstrated endothelial dysfunction, mesenchymal gene activation, and epigenetic activation of RUNX1 following loss of LMNA-mediated repression. Genetic RUNX1 deletion restored endothelial identity, reversed EndoMT-associated transcriptional programmes, and normalized chromatin accessibility at endothelial regulatory loci. In multicellular cardiac organoids, endothelial RUNX1 activation impaired endothelial-cardiomyocyte signalling and cardiomyocyte contractile function, whereas endothelial-specific RUNX1 deletion restored endothelial and myocardial function. Pharmacological RUNX1 inhibition with Ro24-7429 similarly improved endothelial and cardiomyocyte function in vitro and reduced myocardial fibrosis while preserving cardiac function in LMNAH222P/H222P mice, including after disease onset. Conclusions: RUNX1-driven EndoMT represents a central mechanism linking LMNA mutations to fibrotic remodelling in LMNA cardiomyopathy. These findings support endothelial transcriptional reprogramming and RUNX1 signalling as potential therapeutic targets in fibrotic cardiomyopathy.Keywords
Funding Information
- National Institutes of Health
- Norges Idrettshøgskole (R35HL183578)
- Norges Idrettshøgskole (R01HL158641)
- Norges Idrettshøgskole (R01HL161002)
- Norges Idrettshøgskole (K01HL135455)
- Norges Idrettshøgskole (R01HL130020)
- Norges Idrettshøgskole (R01HL141371)
- Norges Idrettshøgskole (UM1TR006031)
- American Heart Association
- Animal Health Australia (869015)
- Comissão Interministerial para os Recursos do Mar (23POST1020812)
- Comissão Interministerial para os Recursos do Mar (25CDA1456151)
This publication has 63 references indexed in Scilit:
- LMNA-related cardiomyopathy: From molecular pathology to cardiac gene therapyJournal of Advanced Research, 2025
- LMNA Cardiomyopathy: Important Considerations for the Heart Failure ClinicianJournal of Cardiac Failure, 2023
- Isolation of Cardiac Endothelial Cells for Transcriptomic Analysis of the Zebrafish and Mouse Heart2022
- Targeting Runt-Related Transcription Factor 1 Prevents Pulmonary Fibrosis and Reduces Expression of Severe Acute Respiratory Syndrome Coronavirus 2 Host MediatorsThe American Journal of Pathology, 2021
- Case Series: LMNA -Related Dilated Cardiomyopathy Presents with Reginal Wall Akinesis and Transmural Late Gadolinium EnhancementESC Heart Failure, 2020
- Endothelial to Mesenchymal Transition in Cardiovascular DiseaseJACC, 2019
- CMR-Verified Interstitial Myocardial Fibrosis as a Marker of Subclinical Cardiac Involvement in LMNA Mutation CarriersJACC: Cardiovascular Imaging, 2013
- The Role of Endothelial Dysfunction in the Development of Myocardial Fibrosis in Dilated CardiomyopathyHeart, Lung and Circulation, 2009
- Severe Myocardial Fibrosis Caused by a Deletion of the 5’ End of the Lamin A/C GeneJACC, 2007
- Myocardial Biopsy Findings and Gadolinium Enhanced Cardiovascular Magnetic Resonance in Dilated CardiomyopathyEuropean Journal of Heart Failure, 2006